✦ LIBER ✦

Cisplatin and vinorelbine as second-line chemotherapy in patients with advanced non-small cell lung cancer (NSCLC) resistant to taxol plus gemcitabine

✍ Scribed by De Pas, Tommaso; de Braud, Filippo; Mandalà, Mario; Curigliano, Giuseppe; Catania, Chiara; Ferretti, Gianluigi; Sozzi, Pietro; Solli, Piergiorgio; Goldhirsch, Aron

Book ID: 118569470
Publisher: Elsevier Science
Year: 2001
Tongue: English
Weight: 55 KB
Volume: 31
Category: Article
ISSN: 0169-5002
DOI: 10.1016/s0169-5002(00)00176-8

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Cisplatin plus vinorelbine or gemcitabin

Cisplatin plus vinorelbine or gemcitabine in patients with advanced non-small cell lung cancer: Pharmacoeconomic considerations

✍ Dyfrig A. Hughes 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 53 KB

Vinorelbine, ifosfamide and cisplatin (N

Vinorelbine, ifosfamide and cisplatin (NIP) as first line chemotherapy in patients with non-small-cell lung cancer (NSCLC)

✍ Teixeira, E; Sotto-Mayor, R; Borges, M; Bugalho de Almeida, A 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 104 KB

Nimotuzumab combined with gemcitabine an

Nimotuzumab combined with gemcitabine and cisplatin as second-line chemotherapy for advanced non-small-cell lung cancer

✍ Hua-qing Wang; Yangang Ren; Zheng-zi Qian; Kai Fu; Hui-lai Zhang; Wei Li; Yun Ho 📂 Article 📅 2012 🏛 Wiley (Blackwell Publishing) 🌐 English ⚖ 149 KB

Second-line treatment with gemcitabine a

Second-line treatment with gemcitabine and vinorelbine in non-small-cell lung cancer (NSCLC) cisplatin failures: a pilot study

✍ Herrero, Carlos Camps; Noguerón Martı́nez, Esther; Jaime, Alfonso Berrocal 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 74 KB

Corrigendum to “Second line treatment wi

Corrigendum to “Second line treatment with gemcitabine and vinorelbine in non-small-cell lung cancer (NSCLC) cisplatin failures: a pilot study”

✍ Camps, Carlos; Noguerón Martı́nez, Esther; Berrocal Jaime, Alfonso 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 37 KB

Phase II study of Gemcitabine, Ifosfamid

Phase II study of Gemcitabine, Ifosfamide plus Vinorelbine (GIN) as a first-line chemotherapy in advanced non-small cell lung cancer (NSCLC): A promising non-cisplatin based regimen

✍ Castellano, D; Lianes, P; Arcediano, A; Gómez-Martin, C; Ciruelos, E; Bezares, S 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 106 KB